The global circulating tumor cell (ctc) testing market size was valued at USD 9.4 billion in 2021 and is expected to reach USD 16.4 billion by 2028, at a CAGR of 11.7% during the forecast period 2022-2028. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on " Global Circulating Tumor Cell (CTC) Testing Market: Technology (CTC detection (Functional in-vitro cell invasion assay, Molecular(RNA) based technologies, Xenotransplantation models, Immunocytochemical technologies, EPISPOT functional in-vitro cell culture), (CTC Enrichment (Microchips, In-vivo positive selection, Single spiral micro channel, Ex-vivo positive selection, Negative selection), CTC Analysis), Application (EMT biomarkers development, Cancer stem cell research, Tumorigenesis research, Others), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography- Global/Region/Country Forecast to 2028",

View detailed Report Description at https://precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/

Growing Awareness about Circulating Tumor Cell Test is Driving the Market Growth

Circulating tumor cell testing is one of the simple blood tests used to evaluate the prognosis of patients with metastatic colorectal, prostate cancer. FDA approved, the cell search test is used for CTC evaluation. CTC’s are the cancer cells, which separate from solid tumors and go into the blood stream. CTC’s are not detected often. Average only 1 CTC is found in 1 billion blood cells and CTC clusters are rarer. The significant development in the market in terms of CTC cluster is the development of cluster chip greatly helps to identify CTC clusters ranging between 2-7 cells.

A few factors are there, which are fuelling the circulating tumor cell (CTC) testing market such as growing aged population and growing count of cancer patients. Cancer causes 13% of deaths every year according the to the WHO statistics every year. Furthermore, 70% increase in the cases of cancer is projected over the upcoming couple of decades. Aged population is also projected to almost double the cancer occurring rate from 12% to 22% during the estimation period. Moreover, huge government support, advanced technologies to circulate tumor cell testing and increase in consciousness about circulating tumor cell will drive the circulating tumor cell testing market growth over the forecast period. On the other hand, extended time required to approve the product launchings and strict regulatory framework are some factors hampering the market growth globally.

Request sample research report https://precisionbusinessinsights.com/request-sample?product_id=22263

North America is dominating the Circulating Tumor Cell (CTC) Testing Market

On the basis of regional analysis, global market is categorized into several major regions such as Europe, North America, Asia Pacific, Middle East, Latin America and Africa. Among all the regions, North America is leading the market because of several factors such as huge investments made in research and development activities, growing aging population, government support and technological development in the region will propel the industry demand. Increase in cancer patients and growing acceptance of advanced technology are the factors projected to drive the UK market over the forecast duration. Market in Asia Pacific is projected to record high growth owing to increasing healthcare infrastructure, growing initiatives by government and increasing economy in the region.

Competitive Analysis

A few key players profiled in the global circulating tumor cell (CTC) testing market are Fluxion Biosciences (U.S.), Adnagen (Germany), Apocell (U.S.), Advanced Cell Diagnostics (U.S.), Cynvenio Biosystems (U.S.), Aviva Biosciences (U.S.), Biocept Inc. (U.S.)

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747